
As the digital medium poses new threats to brand equity and public safety for pharma, what can drugmakers do to better balance its essential communications benefits with the risks?
As the digital medium poses new threats to brand equity and public safety for pharma, what can drugmakers do to better balance its essential communications benefits with the risks?
Perspectives from a board member and an aspiring board member on how to increase the number of qualified women on boards.
Published: December 14th 2022 | Updated: